Xeriant, Inc.
Xeriant, Inc. (XERI) Financial Performance & Income Statement Overview
Analyze Xeriant, Inc. (XERI) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Xeriant, Inc. (XERI) Income Statement & Financial Overview
Analyze Xeriant, Inc.’s XERI earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $13573.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | -$13573.00 |
| Gross Profit Ratio | ||||
| R&D Expenses | $30224.00 | $15.00 | $26561.00 | $49163.00 |
| SG&A Expenses | $173594.00 | $335568.00 | $120251.00 | $844948.00 |
| Operating Expenses | $458918.00 | $335583.00 | $358795.00 | $894111.00 |
| Total Costs & Expenses | $0.00 | $335583.00 | $358795.00 | $894111.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$66153.00 | $76851.00 | $78419.00 | $304614.00 |
| Depreciation & Amortization | $0.00 | $14327.00 | $378.00 | $51036.00 |
| EBITDA | -$458918.00 | -$326091.00 | -$279859.00 | -$851911.00 |
| EBITDA Ratio | ||||
| Operating Income | -$458918.00 | -$335583.00 | -$358795.00 | -$894111.00 |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | -$71350.00 | -$81686.00 | -$13427.00 | -$275987.00 |
| Income Before Tax | -$530268.00 | -$417269.00 | -$372222.00 | -$1.17M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | -$2612.00 | -$7219.00 | -$7376.00 | $0.00 |
| Net Income | -$527656.00 | -$410050.00 | -$364846.00 | -$1.16M |
| Net Income Ratio | ||||
| EPS | -$0.001 | -$0.001 | -$0.001 | -$0.003 |
| Diluted EPS | -$0.001 | -$0.001 | -$0.001 | -$0.003 |
| Weighted Avg Shares Outstanding | $654.80M | $596.20M | $547.58M | $443.26M |
| Weighted Avg Shares Outstanding (Diluted) | $654.80M | $596.20M | $547.58M | $443.26M |
Financial performance has remained strong, with revenue growing from $0.00 in Q4 2024 to $0.00 in Q3 2025. Gross profit continued to perform well, with margins at N/A in the latest quarter. Operating income reached -$458918.00 in Q3 2025, holding a steady N/A margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$458918.00. Net income dropped to -$527656.00, keeping EPS at -$0.001. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan